Thank you to everyone who responded to my first post a couple of months ago, regarding an extension to TCZ.
An update for you…..
As suggested by Lemonzest I’ve exchanged a few emails with Roche UK, and here’s their response:
“I have discussed your query with our Medical Affairs team and they have confirmed that unfortunately funding extensions are no longer available in the UK for RoActemra. We can only recommend that you discuss this further with your doctor as they are best placed to provide advice on how to access and obtain funding for medicines in the UK.”
So that’s that.
As regards the possibility of additional funding from my local NHS Trust, although my consultant has lobbied hard for this, the Trust has now formally refused. That’s unsurprising, but nonetheless disappointing.
So, my next step is to explore the possibility of moving to sarilumab, another IL-6 inhibitor, but that’s unlikely as I don’t think it’s been licensed for GCA yet. Unless anyone knows any different?
After that, the only possibility left is to see if I can get an extension via a private rheumy and pay for it privately.
Will keep you updated……